What will be the price of cimipilimab in 2025? Will the price differ in different regions and pharmacies?

Cemiplimab (Cemiplimab) is an immune checkpoint inhibitor mainly used to treat advanced or metastatic cutaneous squamous cell carcinoma, non-small cell lung cancer and other cancers. The drug restores the normal function of the immune system by inhibiting the binding of the PD-1 (programmed death receptor 1) receptor to its ligand, helping immune cells recognize and attack tumor cells. However, cimepilimab is not yet available in China, so its price information is unclear.

Currently, the original drug of cimepilimab is available overseas, especially in the U.S. and European markets. Common specifications are 350mg/7mL (50mg/mL), and each box may be sold for between 40,000 and 100,000 yuan. Price differences are mainly affected by factors such as exchange rate fluctuations, regional pricing strategies, and pharmaceutical supply chains. Taking the U.S. market as an example, the price of cimepilimab is usually relatively expensive, while in Europe, although the price may be relatively cheaper, it is still a high-priced drug, mainly affected by the local medical insurance system and drug pricing policies.

Since cimepilimab is not yet on the market in China and is not covered by medical insurance, it cannot be purchased directly through domestic pharmacies or hospitals. Nonetheless, if patients require treatment with this drug, they may need to obtain it through overseas drug purchase channels. This type of medicine is usually purchased through international pharmacies, overseas direct mail or agents, but you need to pay attention to issues such as customs policies, transportation time and additional charges when purchasing. In addition, given the higher drug prices, patients may have to pay more expensive fees.

It is worth noting that there are currently no generic drugs of cimepilimab on the market, which means that only original drugs are available on the market, and patients may face higher treatment costs. Over time, as the drug is launched in China and included in medical insurance, the price is expected to be gradually transparent and reduced. However, at present, patients mainly rely on overseas channels to obtain drugs and pay higher prices.

In summary, the price of cimepilimab may vary between different regions and pharmacies, especially in the international market, where prices fluctuate greatly. Patients should be fully informed about prices, exchange rate changes, and drug sources when purchasing to ensure they receive a safe and affordable treatment option.

Reference materials:https://www.libtayohcp.com/